[1]
“Semaglutide, Tirzepatide and the Cardiologist: Weight-Directed Therapy as Cardiovascular Therapy”, JHCS, vol. 5, no. 1, pp. 1–3, Sep. 2024, doi: 10.5281/zenodo.22365904.